These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2073763)

  • 1. Intratympanic gentamycin in severe Ménière's disease.
    Laitakari K
    Clin Otolaryngol Allied Sci; 1990 Dec; 15(6):545-8. PubMed ID: 2073763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of intratympanic gentamycin for the treatment of Meniere's disease].
    Krzeska-Malinowska I; Pierchała K; Held-Ziółkowska M; Niemczyk K; Kowalska M
    Otolaryngol Pol; 2001; 55(6):623-6. PubMed ID: 15852786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New possibilities in the treatment of Meniere's disease].
    Milanović N; Kitanoski B; Ristić B; Jaćimović V
    Vojnosanit Pregl; 2002; 59(1):11-5. PubMed ID: 11928183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current role of local intratympanic gentamicin therapy in the management of unilateral Menière's disease.
    Pfleiderer AG
    Clin Otolaryngol Allied Sci; 1998 Feb; 23(1):34-41. PubMed ID: 9563663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose intratympanic gentamicin and the treatment of Meniere's disease: preliminary results.
    Driscoll CL; Kasperbauer JL; Facer GW; Harner SG; Beatty CW
    Laryngoscope; 1997 Jan; 107(1):83-9. PubMed ID: 9001270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of Ménière's disease with intratympanically applied gentamycin sulphate (author's transl)].
    Katzke D
    Laryngol Rhinol Otol (Stuttg); 1982 Jan; 61(1):4-8. PubMed ID: 7098690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratympanic gentamycin therapy for Menière's disease placed by tubal catheter with systemic isosorbide.
    Yamazaki T; Hayashi M; Hayashi N; Kozaki H
    Arch Otorhinolaryngol; 1988; 245(3):170-4. PubMed ID: 3178565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratympanic gentamicin therapy for Menière's disease placed by a tubal catheter with systematic isosorbide.
    Yamazaki T; Hayashi M; Komatsuzaki A
    Acta Otolaryngol Suppl; 1991; 481():613-6. PubMed ID: 1927484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of intratympanic gentamicin for treatment of Ménière's disease on lower frequency hearing.
    Sam G; Chung DW; van der Hoeven R; Verweij S; Becker M
    Int J Clin Pharm; 2016 Aug; 38(4):780-3. PubMed ID: 27073077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The intratympanic treatment of Menière's disease with ototoxic antibiotics. A follow-up study of 55 cases (author's transl)].
    Lange G
    Laryngol Rhinol Otol (Stuttg); 1977 May; 56(5):409-14. PubMed ID: 141554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
    Quaranta A; Aloisi A; De Benedittis G; Scaringi A
    Ann N Y Acad Sci; 1999 Nov; 884():410-24. PubMed ID: 10842610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intratympanic gentamicin treatment for intractable Menière's disease].
    Gilony D; Wolf M; Kronenberg J
    Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of intractable Menière's disease with intratympanic gentamicin: review of the University of Ottawa experience.
    Corsten M; Marsan J; Schramm D; Robichaud J
    J Otolaryngol; 1997 Dec; 26(6):361-4. PubMed ID: 9438932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign paroxysmal positional vertigo in patients with Ménière's disease treated with intratympanic gentamycin.
    Perez N; Martin E; Zubieta JL; Romero MD; Garcia-Tapia R
    Laryngoscope; 2002 Jun; 112(6):1104-9. PubMed ID: 12160282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.
    Kaplan DM; Hehar SS; Bance ML; Rutka JA
    Laryngoscope; 2002 Apr; 112(4):689-95. PubMed ID: 12150525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intratympanic gentamicin in Menière's disease].
    Huang W; Xu H; Gao B
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 18(1):14-6. PubMed ID: 15088342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.